Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.5.3, replacing v3.5.2. This indicates a small update to the page version rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-04-30T14:21:23.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision update: v3.5.0 replaced by v3.5.2. This update includes backend and UI improvements and does not modify study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-04-16T10:25:06.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    - Updated page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:43:06.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added Thymus cancer to the related conditions and included a Genetic and Rare Diseases Information Center resources link.
    Difference
    0.2%
    Check dated 2026-03-18T14:52:35.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:14:11.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the notice about lapse in government funding and the Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:43:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.